The stock sinks after the medical device marker slashes its full-year guidance.
News & Analysis: Inogen
INGN earnings call for the period ending March 31, 2019.
John talks to Tucker Walsh and Rayna Lesser Hannaway, the two portfolio managers of the Polen U.S. Small Company Growth Strategy, about Paycom, EPAM Systems, and more.
The medical technology company issued fourth-quarter and full-year 2018 earnings.
INGN earnings call for the period ending December 31, 2018.
Inogen stock got crushed in the tech rout, giving investors a second bite at the apple.
INGN earnings call for the period ending September 30, 2018.
This healthcare company is growing fast and is up 400% over the past three years. Here's why investors can expect the good times to continue.
Geron, Sucampo Pharmaceuticals, and Inogen might be three hidden gems in the healthcare sector.
A Senate showdown looms on the medical device tax. As the repeal gains steam and grabs headlines, what stocks should you be watching?